- Diana Romero
The activity of the Molecular Diagnostics Unit (MDU) focuses primarily on providing a wide range of reliable and time/cost efficient molecular diagnostic assays to clinicians working in hospitals of the Spanish National Health System, with the aim of helping them manage their patients with different malignancies. Therefore, we work to strengthen, update and expand the assays that are currently offered by implementing the latest diagnostic tests available, or by upgrading the most established ones. In parallel, MDU is also devoted to providing support to the Clinical Research Units and Research Groups at the CNIO by collaborating with them through our technical expertise in the field, for example, by developing novel solutions for their research needs. Furthermore, MDU collaborates with international and national associations dedicated to standardising and improving molecular diagnostics in cancer.
Finally, our Unit remains committed towards its policy of training and mentoring students, technicians and medical residents in our techniques and methods.
- (2019). Tumor-associated macrophage-secreted 14-3-3? signals via AXL to promote pancreatic cancer chemoresistance. Oncogene 38, 5469-5485. CNIO Publication.
- (2015). Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.. Arch Pathol Lab Med 139, 522-529. CNIO Publication.